We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FHN icon
126
First Horizon
FHN
$12.1B
$1.1M 0.07%
50,280
+47,187
+1,526% +$1.06M
TMO icon
127
Thermo Fisher Scientific
TMO
$202B
$1.1M 0.07%
2,021
+119
+6% +$65.5K
RGLD icon
128
Royal Gold
RGLD
$16.2B
$1.05M 0.07%
+9,828
New +$1.22M
GIL icon
129
Gildan
GIL
$9.92B
$1.04M 0.07%
36,155
-155,553
-81% -$4.98M
ABT icon
130
Abbott
ABT
$172B
$1.02M 0.06%
9,390
+652
+7% +$74K
DSGX icon
131
Descartes Systems
DSGX
$6.5B
$965K 0.06%
+15,555
New +$971K
MCD icon
132
McDonald's
MCD
$194B
$955K 0.06%
3,869
+257
+7% +$63.3K
MEOH icon
133
Methanex
MEOH
$4.11B
$928K 0.06%
24,344
+4,162
+21% +$205K
CMCSA icon
134
Comcast
CMCSA
$86.1B
$902K 0.06%
22,984
+2,524
+12% +$108K
GOOGL icon
135
Alphabet (Google) Class A
GOOGL
$4.33T
$889K 0.06%
8,160
+6,640
+437% +$782K
UTHR icon
136
United Therapeutics
UTHR
$22.5B
$888K 0.06%
+3,767
New +$766K
DIS icon
137
Walt Disney
DIS
$173B
$885K 0.06%
9,375
+581
+7% +$64.5K
BAC icon
138
Bank of America
BAC
$432B
$843K 0.05%
27,075
+15,363
+131% +$553K
DHR icon
139
Danaher
DHR
$145B
$842K 0.05%
3,748
+248
+7% +$57.1K
IBM icon
140
IBM
IBM
$206B
$793K 0.05%
5,616
+1,253
+29% +$169K
WFC icon
141
Wells Fargo
WFC
$267B
$790K 0.05%
20,158
+1,135
+6% +$49.8K
TSN icon
142
Tyson Foods
TSN
$20.4B
$778K 0.05%
9,044
-1,411
-13% -$126K
HSY icon
143
Hershey
HSY
$35.4B
$776K 0.05%
3,606
+2,827
+363% +$616K
FDS icon
144
Factset
FDS
$9.33B
$773K 0.05%
2,009
-1,887
-48% -$739K
TAL icon
145
TAL Education Group
TAL
$5.67B
$757K 0.05%
155,457
-90,750
-37% -$347K
COR icon
146
Cencora
COR
$59.9B
$753K 0.05%
5,322
+4,460
+517% +$682K
QCOM icon
147
Qualcomm
QCOM
$180B
$751K 0.05%
5,881
+647
+12% +$87.9K
ABMD
148
DELISTED
Abiomed Inc
ABMD
$737K 0.05%
2,978
-36,225
-92% -$9.78M
ELV icon
149
Elevance Health
ELV
$80.9B
$693K 0.04%
1,437
+258
+22% +$128K
AMGN icon
150
Amgen
AMGN
$201B
$689K 0.04%
2,832
+167
+6% +$40.9K
4 5
6
7 8

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.